Cerulean Reports Third-Quarter 2014 Corporate Highlights and Financial Results
13 nov. 2014 16h06 HE
|
Daré Bioscience, Inc.
CAMBRIDGE, Mass., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today provided an update on corporate activities during the quarter...